ACADIA Pharmaceuticals Inc (ACAD)
16.18
-0.09
(-0.55%)
USD |
NASDAQ |
Nov 21, 16:00
16.20
+0.02
(+0.09%)
Pre-Market: 20:00
ACADIA Pharmaceuticals Total Assets (Quarterly): 976.87M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 976.87M |
| June 30, 2024 | 914.10M |
| March 31, 2024 | 855.10M |
| December 31, 2023 | 748.96M |
| September 30, 2023 | 632.54M |
| June 30, 2023 | 642.77M |
| March 31, 2023 | 655.30M |
| December 31, 2022 | 587.81M |
| September 30, 2022 | 602.49M |
| June 30, 2022 | 612.77M |
| March 31, 2022 | 624.25M |
| December 31, 2021 | 700.12M |
| September 30, 2021 | 717.67M |
| June 30, 2021 | 724.43M |
| March 31, 2021 | 755.17M |
| December 31, 2020 | 782.62M |
| September 30, 2020 | 795.66M |
| June 30, 2020 | 759.65M |
| March 31, 2020 | 747.45M |
| December 31, 2019 | 783.18M |
| September 30, 2019 | 765.59M |
| June 30, 2019 | 460.88M |
| March 31, 2019 | 501.10M |
| December 31, 2018 | 540.20M |
| September 30, 2018 | 266.46M |
| Date | Value |
|---|---|
| June 30, 2018 | 314.96M |
| March 31, 2018 | 351.04M |
| December 31, 2017 | 384.51M |
| September 30, 2017 | 413.71M |
| June 30, 2017 | 456.32M |
| March 31, 2017 | 503.01M |
| December 31, 2016 | 561.15M |
| September 30, 2016 | 617.38M |
| June 30, 2016 | 438.03M |
| March 31, 2016 | 466.59M |
| December 31, 2015 | 221.90M |
| September 30, 2015 | 245.32M |
| June 30, 2015 | 275.54M |
| March 31, 2015 | 301.96M |
| December 31, 2014 | 325.46M |
| September 30, 2014 | 341.76M |
| June 30, 2014 | 359.46M |
| March 31, 2014 | 373.51M |
| December 31, 2013 | 189.12M |
| September 30, 2013 | 199.28M |
| June 30, 2013 | 206.91M |
| March 31, 2013 | 103.02M |
| December 31, 2012 | 108.59M |
| September 30, 2012 | 23.75M |
| June 30, 2012 | 21.87M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
587.81M
Minimum
Dec 2022
976.87M
Maximum
Sep 2024
730.95M
Average
735.94M
Median
Total Assets (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 93.67B |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 399.69M |
| Shareholders Equity (Quarterly) | 577.18M |
| Current Ratio | 2.292 |